Global mRNA Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
According to our (Global Info Research) latest study, the global mRNA Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global mRNA Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global mRNA Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global mRNA Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global mRNA Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc. and Astrazeneca and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
mRNA Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe mRNA Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Therapy, with revenue, gross margin and global market share of mRNA Therapy from 2018 to 2023.
Chapter 3, the mRNA Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and mRNA Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Therapy.
Chapter 13, to describe mRNA Therapy research findings and conclusion.
According to our (Global Info Research) latest study, the global mRNA Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global mRNA Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global mRNA Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global mRNA Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global mRNA Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc. and Astrazeneca and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
mRNA Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Vaccine
- Drugs
- mRNA Targeted Delivery in vivo
- Genetically Modified T cells
- Transforming Nanoparticles to Develop Immunotherapy for Cancer
- Small Molecule Drugs Discovery
- Moderna
- BioNTech
- Pfizer
- Arcturus Therapeutics Holdings Inc.
- Astrazeneca
- CureVac
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe mRNA Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Therapy, with revenue, gross margin and global market share of mRNA Therapy from 2018 to 2023.
Chapter 3, the mRNA Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and mRNA Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Therapy.
Chapter 13, to describe mRNA Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of mRNA Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Therapy by Type
1.3.1 Overview: Global mRNA Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global mRNA Therapy Consumption Value Market Share by Type in 2022
1.3.3 Vaccine
1.3.4 Drugs
1.4 Global mRNA Therapy Market by Application
1.4.1 Overview: Global mRNA Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 mRNA Targeted Delivery in vivo
1.4.3 Genetically Modified T cells
1.4.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
1.4.5 Small Molecule Drugs Discovery
1.5 Global mRNA Therapy Market Size & Forecast
1.6 Global mRNA Therapy Market Size and Forecast by Region
1.6.1 Global mRNA Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global mRNA Therapy Market Size by Region, (2018-2029)
1.6.3 North America mRNA Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe mRNA Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific mRNA Therapy Market Size and Prospect (2018-2029)
1.6.6 South America mRNA Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa mRNA Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna mRNA Therapy Product and Solutions
2.1.4 Moderna mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Moderna Recent Developments and Future Plans
2.2 BioNTech
2.2.1 BioNTech Details
2.2.2 BioNTech Major Business
2.2.3 BioNTech mRNA Therapy Product and Solutions
2.2.4 BioNTech mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioNTech Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer mRNA Therapy Product and Solutions
2.3.4 Pfizer mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Arcturus Therapeutics Holdings Inc.
2.4.1 Arcturus Therapeutics Holdings Inc. Details
2.4.2 Arcturus Therapeutics Holdings Inc. Major Business
2.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product and Solutions
2.4.4 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Arcturus Therapeutics Holdings Inc. Recent Developments and Future Plans
2.5 Astrazeneca
2.5.1 Astrazeneca Details
2.5.2 Astrazeneca Major Business
2.5.3 Astrazeneca mRNA Therapy Product and Solutions
2.5.4 Astrazeneca mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Astrazeneca Recent Developments and Future Plans
2.6 CureVac
2.6.1 CureVac Details
2.6.2 CureVac Major Business
2.6.3 CureVac mRNA Therapy Product and Solutions
2.6.4 CureVac mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CureVac Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of mRNA Therapy by Company Revenue
3.2.2 Top 3 mRNA Therapy Players Market Share in 2022
3.2.3 Top 6 mRNA Therapy Players Market Share in 2022
3.3 mRNA Therapy Market: Overall Company Footprint Analysis
3.3.1 mRNA Therapy Market: Region Footprint
3.3.2 mRNA Therapy Market: Company Product Type Footprint
3.3.3 mRNA Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global mRNA Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global mRNA Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Therapy Consumption Value by Type (2018-2029)
6.2 North America mRNA Therapy Consumption Value by Application (2018-2029)
6.3 North America mRNA Therapy Market Size by Country
6.3.1 North America mRNA Therapy Consumption Value by Country (2018-2029)
6.3.2 United States mRNA Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada mRNA Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico mRNA Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe mRNA Therapy Consumption Value by Type (2018-2029)
7.2 Europe mRNA Therapy Consumption Value by Application (2018-2029)
7.3 Europe mRNA Therapy Market Size by Country
7.3.1 Europe mRNA Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany mRNA Therapy Market Size and Forecast (2018-2029)
7.3.3 France mRNA Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom mRNA Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia mRNA Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy mRNA Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific mRNA Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific mRNA Therapy Market Size by Region
8.3.1 Asia-Pacific mRNA Therapy Consumption Value by Region (2018-2029)
8.3.2 China mRNA Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan mRNA Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea mRNA Therapy Market Size and Forecast (2018-2029)
8.3.5 India mRNA Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia mRNA Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia mRNA Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America mRNA Therapy Consumption Value by Type (2018-2029)
9.2 South America mRNA Therapy Consumption Value by Application (2018-2029)
9.3 South America mRNA Therapy Market Size by Country
9.3.1 South America mRNA Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil mRNA Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina mRNA Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa mRNA Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa mRNA Therapy Market Size by Country
10.3.1 Middle East & Africa mRNA Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey mRNA Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia mRNA Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE mRNA Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 mRNA Therapy Market Drivers
11.2 mRNA Therapy Market Restraints
11.3 mRNA Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Therapy Industry Chain
12.2 mRNA Therapy Upstream Analysis
12.3 mRNA Therapy Midstream Analysis
12.4 mRNA Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of mRNA Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Therapy by Type
1.3.1 Overview: Global mRNA Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global mRNA Therapy Consumption Value Market Share by Type in 2022
1.3.3 Vaccine
1.3.4 Drugs
1.4 Global mRNA Therapy Market by Application
1.4.1 Overview: Global mRNA Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 mRNA Targeted Delivery in vivo
1.4.3 Genetically Modified T cells
1.4.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
1.4.5 Small Molecule Drugs Discovery
1.5 Global mRNA Therapy Market Size & Forecast
1.6 Global mRNA Therapy Market Size and Forecast by Region
1.6.1 Global mRNA Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global mRNA Therapy Market Size by Region, (2018-2029)
1.6.3 North America mRNA Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe mRNA Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific mRNA Therapy Market Size and Prospect (2018-2029)
1.6.6 South America mRNA Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa mRNA Therapy Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna mRNA Therapy Product and Solutions
2.1.4 Moderna mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Moderna Recent Developments and Future Plans
2.2 BioNTech
2.2.1 BioNTech Details
2.2.2 BioNTech Major Business
2.2.3 BioNTech mRNA Therapy Product and Solutions
2.2.4 BioNTech mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioNTech Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer mRNA Therapy Product and Solutions
2.3.4 Pfizer mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Arcturus Therapeutics Holdings Inc.
2.4.1 Arcturus Therapeutics Holdings Inc. Details
2.4.2 Arcturus Therapeutics Holdings Inc. Major Business
2.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product and Solutions
2.4.4 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Arcturus Therapeutics Holdings Inc. Recent Developments and Future Plans
2.5 Astrazeneca
2.5.1 Astrazeneca Details
2.5.2 Astrazeneca Major Business
2.5.3 Astrazeneca mRNA Therapy Product and Solutions
2.5.4 Astrazeneca mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Astrazeneca Recent Developments and Future Plans
2.6 CureVac
2.6.1 CureVac Details
2.6.2 CureVac Major Business
2.6.3 CureVac mRNA Therapy Product and Solutions
2.6.4 CureVac mRNA Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CureVac Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of mRNA Therapy by Company Revenue
3.2.2 Top 3 mRNA Therapy Players Market Share in 2022
3.2.3 Top 6 mRNA Therapy Players Market Share in 2022
3.3 mRNA Therapy Market: Overall Company Footprint Analysis
3.3.1 mRNA Therapy Market: Region Footprint
3.3.2 mRNA Therapy Market: Company Product Type Footprint
3.3.3 mRNA Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global mRNA Therapy Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global mRNA Therapy Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Therapy Consumption Value by Type (2018-2029)
6.2 North America mRNA Therapy Consumption Value by Application (2018-2029)
6.3 North America mRNA Therapy Market Size by Country
6.3.1 North America mRNA Therapy Consumption Value by Country (2018-2029)
6.3.2 United States mRNA Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada mRNA Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico mRNA Therapy Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe mRNA Therapy Consumption Value by Type (2018-2029)
7.2 Europe mRNA Therapy Consumption Value by Application (2018-2029)
7.3 Europe mRNA Therapy Market Size by Country
7.3.1 Europe mRNA Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany mRNA Therapy Market Size and Forecast (2018-2029)
7.3.3 France mRNA Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom mRNA Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia mRNA Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy mRNA Therapy Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific mRNA Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific mRNA Therapy Market Size by Region
8.3.1 Asia-Pacific mRNA Therapy Consumption Value by Region (2018-2029)
8.3.2 China mRNA Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan mRNA Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea mRNA Therapy Market Size and Forecast (2018-2029)
8.3.5 India mRNA Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia mRNA Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia mRNA Therapy Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America mRNA Therapy Consumption Value by Type (2018-2029)
9.2 South America mRNA Therapy Consumption Value by Application (2018-2029)
9.3 South America mRNA Therapy Market Size by Country
9.3.1 South America mRNA Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil mRNA Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina mRNA Therapy Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa mRNA Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa mRNA Therapy Market Size by Country
10.3.1 Middle East & Africa mRNA Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey mRNA Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia mRNA Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE mRNA Therapy Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 mRNA Therapy Market Drivers
11.2 mRNA Therapy Market Restraints
11.3 mRNA Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Therapy Industry Chain
12.2 mRNA Therapy Upstream Analysis
12.3 mRNA Therapy Midstream Analysis
12.4 mRNA Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global mRNA Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global mRNA Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global mRNA Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Moderna Company Information, Head Office, and Major Competitors
Table 6. Moderna Major Business
Table 7. Moderna mRNA Therapy Product and Solutions
Table 8. Moderna mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Moderna Recent Developments and Future Plans
Table 10. BioNTech Company Information, Head Office, and Major Competitors
Table 11. BioNTech Major Business
Table 12. BioNTech mRNA Therapy Product and Solutions
Table 13. BioNTech mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BioNTech Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer mRNA Therapy Product and Solutions
Table 18. Pfizer mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Arcturus Therapeutics Holdings Inc. Company Information, Head Office, and Major Competitors
Table 21. Arcturus Therapeutics Holdings Inc. Major Business
Table 22. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product and Solutions
Table 23. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Arcturus Therapeutics Holdings Inc. Recent Developments and Future Plans
Table 25. Astrazeneca Company Information, Head Office, and Major Competitors
Table 26. Astrazeneca Major Business
Table 27. Astrazeneca mRNA Therapy Product and Solutions
Table 28. Astrazeneca mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Astrazeneca Recent Developments and Future Plans
Table 30. CureVac Company Information, Head Office, and Major Competitors
Table 31. CureVac Major Business
Table 32. CureVac mRNA Therapy Product and Solutions
Table 33. CureVac mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. CureVac Recent Developments and Future Plans
Table 35. Global mRNA Therapy Revenue (USD Million) by Players (2018-2023)
Table 36. Global mRNA Therapy Revenue Share by Players (2018-2023)
Table 37. Breakdown of mRNA Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in mRNA Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key mRNA Therapy Players
Table 40. mRNA Therapy Market: Company Product Type Footprint
Table 41. mRNA Therapy Market: Company Product Application Footprint
Table 42. mRNA Therapy New Market Entrants and Barriers to Market Entry
Table 43. mRNA Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global mRNA Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global mRNA Therapy Consumption Value Share by Type (2018-2023)
Table 46. Global mRNA Therapy Consumption Value Forecast by Type (2024-2029)
Table 47. Global mRNA Therapy Consumption Value by Application (2018-2023)
Table 48. Global mRNA Therapy Consumption Value Forecast by Application (2024-2029)
Table 49. North America mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific mRNA Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific mRNA Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 79. mRNA Therapy Raw Material
Table 80. Key Suppliers of mRNA Therapy Raw Materials
Table 1. Global mRNA Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global mRNA Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global mRNA Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Moderna Company Information, Head Office, and Major Competitors
Table 6. Moderna Major Business
Table 7. Moderna mRNA Therapy Product and Solutions
Table 8. Moderna mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Moderna Recent Developments and Future Plans
Table 10. BioNTech Company Information, Head Office, and Major Competitors
Table 11. BioNTech Major Business
Table 12. BioNTech mRNA Therapy Product and Solutions
Table 13. BioNTech mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BioNTech Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer mRNA Therapy Product and Solutions
Table 18. Pfizer mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Arcturus Therapeutics Holdings Inc. Company Information, Head Office, and Major Competitors
Table 21. Arcturus Therapeutics Holdings Inc. Major Business
Table 22. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product and Solutions
Table 23. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Arcturus Therapeutics Holdings Inc. Recent Developments and Future Plans
Table 25. Astrazeneca Company Information, Head Office, and Major Competitors
Table 26. Astrazeneca Major Business
Table 27. Astrazeneca mRNA Therapy Product and Solutions
Table 28. Astrazeneca mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Astrazeneca Recent Developments and Future Plans
Table 30. CureVac Company Information, Head Office, and Major Competitors
Table 31. CureVac Major Business
Table 32. CureVac mRNA Therapy Product and Solutions
Table 33. CureVac mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. CureVac Recent Developments and Future Plans
Table 35. Global mRNA Therapy Revenue (USD Million) by Players (2018-2023)
Table 36. Global mRNA Therapy Revenue Share by Players (2018-2023)
Table 37. Breakdown of mRNA Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in mRNA Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key mRNA Therapy Players
Table 40. mRNA Therapy Market: Company Product Type Footprint
Table 41. mRNA Therapy Market: Company Product Application Footprint
Table 42. mRNA Therapy New Market Entrants and Barriers to Market Entry
Table 43. mRNA Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global mRNA Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global mRNA Therapy Consumption Value Share by Type (2018-2023)
Table 46. Global mRNA Therapy Consumption Value Forecast by Type (2024-2029)
Table 47. Global mRNA Therapy Consumption Value by Application (2018-2023)
Table 48. Global mRNA Therapy Consumption Value Forecast by Application (2024-2029)
Table 49. North America mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific mRNA Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific mRNA Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa mRNA Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa mRNA Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa mRNA Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa mRNA Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa mRNA Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa mRNA Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 79. mRNA Therapy Raw Material
Table 80. Key Suppliers of mRNA Therapy Raw Materials
LIST OF FIGURES
Figure 1. mRNA Therapy Picture
Figure 2. Global mRNA Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Therapy Consumption Value Market Share by Type in 2022
Figure 4. Vaccine
Figure 5. Drugs
Figure 6. Global mRNA Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. mRNA Therapy Consumption Value Market Share by Application in 2022
Figure 8. mRNA Targeted Delivery in vivo Picture
Figure 9. Genetically Modified T cells Picture
Figure 10. Transforming Nanoparticles to Develop Immunotherapy for Cancer Picture
Figure 11. Small Molecule Drugs Discovery Picture
Figure 12. Global mRNA Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global mRNA Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market mRNA Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global mRNA Therapy Consumption Value Market Share by Region (2018-2029)
Figure 16. Global mRNA Therapy Consumption Value Market Share by Region in 2022
Figure 17. North America mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. South America mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Global mRNA Therapy Revenue Share by Players in 2022
Figure 23. mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players mRNA Therapy Market Share in 2022
Figure 25. Global Top 6 Players mRNA Therapy Market Share in 2022
Figure 26. Global mRNA Therapy Consumption Value Share by Type (2018-2023)
Figure 27. Global mRNA Therapy Market Share Forecast by Type (2024-2029)
Figure 28. Global mRNA Therapy Consumption Value Share by Application (2018-2023)
Figure 29. Global mRNA Therapy Market Share Forecast by Application (2024-2029)
Figure 30. North America mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 31. North America mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 32. North America mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 33. United States mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. France mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific mRNA Therapy Consumption Value Market Share by Region (2018-2029)
Figure 47. China mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. India mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. South America mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 54. South America mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 55. South America mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 64. mRNA Therapy Market Drivers
Figure 65. mRNA Therapy Market Restraints
Figure 66. mRNA Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of mRNA Therapy in 2022
Figure 69. Manufacturing Process Analysis of mRNA Therapy
Figure 70. mRNA Therapy Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. mRNA Therapy Picture
Figure 2. Global mRNA Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Therapy Consumption Value Market Share by Type in 2022
Figure 4. Vaccine
Figure 5. Drugs
Figure 6. Global mRNA Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. mRNA Therapy Consumption Value Market Share by Application in 2022
Figure 8. mRNA Targeted Delivery in vivo Picture
Figure 9. Genetically Modified T cells Picture
Figure 10. Transforming Nanoparticles to Develop Immunotherapy for Cancer Picture
Figure 11. Small Molecule Drugs Discovery Picture
Figure 12. Global mRNA Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global mRNA Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market mRNA Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global mRNA Therapy Consumption Value Market Share by Region (2018-2029)
Figure 16. Global mRNA Therapy Consumption Value Market Share by Region in 2022
Figure 17. North America mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. South America mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Global mRNA Therapy Revenue Share by Players in 2022
Figure 23. mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players mRNA Therapy Market Share in 2022
Figure 25. Global Top 6 Players mRNA Therapy Market Share in 2022
Figure 26. Global mRNA Therapy Consumption Value Share by Type (2018-2023)
Figure 27. Global mRNA Therapy Market Share Forecast by Type (2024-2029)
Figure 28. Global mRNA Therapy Consumption Value Share by Application (2018-2023)
Figure 29. Global mRNA Therapy Market Share Forecast by Application (2024-2029)
Figure 30. North America mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 31. North America mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 32. North America mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 33. United States mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. France mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific mRNA Therapy Consumption Value Market Share by Region (2018-2029)
Figure 47. China mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. India mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. South America mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 54. South America mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 55. South America mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa mRNA Therapy Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa mRNA Therapy Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa mRNA Therapy Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE mRNA Therapy Consumption Value (2018-2029) & (USD Million)
Figure 64. mRNA Therapy Market Drivers
Figure 65. mRNA Therapy Market Restraints
Figure 66. mRNA Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of mRNA Therapy in 2022
Figure 69. Manufacturing Process Analysis of mRNA Therapy
Figure 70. mRNA Therapy Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
